Screening of gastric cancer in Asia

Best Practice and Research: Clinical Gastroenterology

Volumn 29, Issue 6, 2015, Pages 895-905

  Sugano, Kentaro ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Helicobacter pylori; Pepsinogen; Primary prevention; Screening; Secondary prevention

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II;

AGE DISTRIBUTION; ARTICLE; BACTERIAL CLEARANCE; CANCER MORTALITY; CANCER SCREENING; CHINA; ENDOSCOPY; FLUOROGRAPHY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PRIMARY PREVENTION; SOUTH KOREA; STOMACH CANCER; TAIWAN; ASIA; COMPLICATION; HELICOBACTER INFECTIONS; INCIDENCE; JAPAN; PROCEDURES; STOMACH NEOPLASMS;

ASIA; ENDOSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; JAPAN; PRIMARY PREVENTION; REPUBLIC OF KOREA; STOMACH NEOPLASMS;

EID: 84945584090     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2015.09.013     Document Type: Review

References (63)

1. International Agency for Research on Cancer Stomach cancer 2012 GLOBOCAN http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx
2. Center for cancer control and information services. http://gdb.ganjoho.jp/graph-db/gdb4.
3. S. Watanabe A mass-screening program as a cancer control strategy Asian Med J 36 1993 341 350
4. K.S. Choi, M.S. Kwak, Hy Lee, J.K. Jun, M.I. Hahm, and E.C. Park Screening for gastric cancer in Korea: population-based preferences for endoscopy versus upper gastrointestinal series Cancer Epidemiol Biomarkers Prev 18 2009 1390 1398
5. Y. Yuan A survey and evaluation of population-based screening for gastric cancer Cancer Biol Med 10 2013 72 80
6. International Agency for Research on Cancer Stomach cancer Schistosomes, liver flukes, and Helicobacter pylori in IARC monographs on the evaluation of the carcinogenic risks to human vol. 61 1994
7. International Agency for Research on Cancer Stomach cancer. Helicobacter in biological agents IARC monographs on the evaluation of carcinogenic risks to human vol. 100B 2012
8. Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst;104:488-92.
9. W.Q. Li, J.L. Ma, L. Zhang, L.M. Brown, J.Y. Li, L. Shen, and et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups J Natl Cancer Inst 106 2014 10.1093/jnci/dju116 Print 2014 Jul
10. Ford ACF, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomized controlled trial. BMJ;348:g3174. http://dx.doi.org/10.1136/bmj.g3174.
11. International Agency for Research on Cancer Helicobacter pylori eradication as a strategy for preventing gastric cancer 2014 IARC Working Group Report 8 Lyon
12. W.K. Leung, M.S. Wu, Y. Kakugawa, J.J. Kim, K.G. Yeoh, K.L. Goh, and et al. Screening for gastric cancer in Asia: current evidence and practice Lancet Oncol 9 2008 279 287
13. C. Hamashima Current issues and future perspectives of gastric cancer screening World J Gastroenterol 20 2014 13767 13774
14. T. Mizoue, T. Yoshimura, N. Tokui, Y. Hoshiyama, H. Yatsuya, K. Sakata, and et al. Prospective study of screening for stomach cancer in Japan Int J Cancer 106 2003 103 107
15. K.J. Lee, M. Inoue, T. Otani, M. Iwasaki, S. Sasazuki, S. Tsugane, and et al. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan Int J Cancer 118 2006 2315 2322
16. H. Suzuki, T. Gotoda, M. Sasako, and D. Saito Detection of early gastric cancer: misunderstanding the role of mass screening Gastric Cancer 9 2006 315 319
17. C. Hamashima, D. Shibuya, H. Yamazaki, M. Inoue, A. Fukao, H. Saito, and et al. The Japanese guidelines for gastric cancer screening Jpn J Clin Oncol 38 2008 259 267
18. A. Tashiro, M. Sano, K. Kinameri, K. Fujita, and Y. Takeuchi Comparing mass screening techniques for gastric cancer in Japan World J Gastroenterol 12 2006 4873 4874
19. S. Matsumoto, K. Yamasaki, K. Tsuji, and S. Shirahama Results of mass endoscopic examination for gastric cancer in Kamigoto Hospital, Nagasaki Prefecture World J Gastroenterol 13 2007 4316 4320
20. J. Yoshino Endoscopic screening for gastric cancer Gastroenterol Endosc 51 2009 325 333 [in Japanese with English abstract]
21. S. Menon, and N. Ttudgill How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis Endosc Int Open 02 2014 E46 E50
22. K. Sugano, K. Sato, and K. Yao New diagnostic approaches for early detection of gastric cancer Dig Dis 22 2004 327 333
23. M. Kato, and M. Asaka Recent development of gastric cancer prevention Jpn J Clin Oncol 42 2012 987 994
24. Research Center for Cancer Prevention and Screening, and National Cancer Center Guidelines for gastric cancer screening based on evaluation of the effectiveness 2014 [In Japanese] http://canscreen.ncc.go.jp/pdf/iganguide2014-150421.pdf 2015
25. O. Hosokawa, T. Miyanaga, Y. Kaizaki, M. Hattori, K. Dohden, K. Ohta, and et al. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry Scand J Gastroenterol 43 2008 1112 1115
26. C. Hamashima, K. Ogoshi, M. Okamoto, M. Shabana, T. Kishimoto, and A. Fukao A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan PLoS One 8 2013 e79088 10.1371/journal.pone.0079088
27. M. Yoshihara, T. Hirayama, S. Yoshida, and et al. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration. A case-control study Scand J Gastroenterol 42 2007 760 764
28. Miki K Gastric cancer screening by combined assay for serum anti-Helicobacter pylori-IgG antibody and serum pepsinogen levels - "ABC method" Proc Jpn Acad Ser B 87 2011 405 414
29. H. Watabe, T. Mitsushima, Y. Yamaji, M. Okamoto, R. Wada, T. Kokubo, and et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study Gut 54 2005 764 768
30. S. Sasazuki, M. Inoue, M. Iwasaki, T. Otani, S. Yamamoto, S. Ikeda, and et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study Cancer Epidemiol Biomarkers Prev 15 2006 1341 1347
31. F. Kitahara, K. Kobayashi, T. Sato, Y. Kojima, T. Araki, and M.A. Fujino Accuracy of screening for gastric cancer using serum pepsinogen concentrations Gut 44 1999 693 697
32. H. Ohata, M. Oka, K. Yanaoka, Y. Shimizu, C. Mukoubayashi, K. Mugitani, and et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography Cancer Sci 96 2005 713 720
33. K. Miki Gastric cancer screening using the serum pepsinogen test method Gastric Cancer 9 2006 245 253
34. T. Yoshida, J. Kato, I. Inoue, N. Yoshimura, H. Deguchi, C. Mukoubayashi, and et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer Int J Cancer 134 2014 1445 1457
35. T. Kawai, K. Miki, M. Ichinose, Y. Kenji, I. Miyazaki, K. Kawakami, and et al. Changes in evaluation of the pepsinogen test results following Helicobacter pylori eradication therapy in Japan Inflammopharmacology 15 2007 31 35
36. N. Shirai, T. Furuta, M. Sugimoto, S. Kanaoka, F. Watanabe, M. Takashima, and et al. Serum pepsinogens as an early diagnostic marker of H. pylori eradication Hepatogastroenterology 55 2008 486 490
37. S. Take, M. Mizuno, K. Ishiki, T. Yoshida, N. Ohara, K. Yokota, and et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori J Gastroenterol 46 2011 318 324
38. S. Mizuno, I. Miki, T. Ishida, M. Yoshida, M. Onoyama, T. Azuma, and et al. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis Dig Dis Sci 55 2010 3132 3137
39. S. Lee, J.K. Jun, M. Suh, B. Park, D.K. Noh, K.W. Jung, and et al. Gastric cancer screening uptake trends in Korea: results for the National Cancer Screening Program from 2002 to 2011 Medicine 94 2015 e533 10.1097/MD.0000000000000533
40. H.Y. Lee, E.C. Park, J.K. Jun, K.S. Choi, and M.I. Hahm Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea World J Gastroenterol 16 2010 245 250
41. K.S. Choi, J.K. Jun, E.C. Park, S. Park, K.W. Jung, M.A. Han, and et al. Performance of different gastric cancer screening methods in Korea: a population-based study PLoS One 7 2012 e50041 10.1371/journal.pone.0050041
42. K.S. Choi, J.K. Jun, M. Suh, B. Park, D.K. Noh, S.H. Song, and et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea Br J Cancer 112 2015 608 612
43. S.Y. Ryu, C.M. Crespi, and A.E. Maxwell Colorectal cancer among Koreans living in South Korea versus California: Incidence, mortality and screening rates Ethn Health 19 2014 406 424
44. J.M. Kang, N. Kim, J.Y. Yoo, Y.S. Park, D.H. Lee, H.Y. Kim, and et al. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea Helicobacter 13 2008 146 156
45. Y.C. Lee, J.T. Lin, H.M. Wu, T.Y. Liu, M.F. Yen, H.M. Chiu, and et al. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer Cancer Epidemiol Biomarkers Prev 16 2007 875 885
46. K.F. Pan, L. Zhang, M. Gerhard, J.L. Ma, W.D. Liu, K. Ulm, and et al. A large randomized controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication Gut 2015 May 18 10.1136/gutjnl-2015-309197 Pii gutjnl-2015-309197
47. Y.C. Lee, T.H. Chen, H.M. Chiu, C.T. Shun, H. Chang, T.Y. Liu, and et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention Gut 62 2013 676 682
48. Y.C. Lee, T.H. Chiang, J.M. Liou, H.H. Chen, M.S. Wu, and D.Y. Graham Mass eradication of Helicobacter pylori to prevent gastric cancer: theoretical and practical considerations Gut Liver 2015 in press
49. Y.C. Lee, H.M. Chiu, T.H. Chiang, A.M. Yen, S.Y. Chiu, S.L. Chen, and et al. Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions BMJ Open 3 2013 e003989 10.1136/bmjopen-2013-003989
50. Y.Y. Dan, J.B.Y. So, and K.G. Yeo Endoscopic screening for gastric cancer Clin Gastroenterol Hepatol 4 2006 709 716
51. H.J. Zhou, Y.Y. Dan, N. Naidoo, S.C. Li, and K.G. Yeoh A cost-effective analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk PLoS One 8 2013 e83959 10.1371/journal.pone.0083959
52. M. Kaise, J. Miwa, J. Tashiro, Y. Ohmoto, S. Morimoto, M. Kato, and et al. the combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk J Gastroenterol 46 2011 736 745
53. S. Aikou, Y. Ohmoto, T. Gunji, N. Matsuhashi, H. Ohtsu, H. Miura, and et al. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening Gastroenterology 141 2011 837 845
54. Kaise M, Miwa J, Fujimoto A, Tashiro J, Tagami D, Sano H, et al. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor e is a stable biomarker.
55. Z. Zeng, S. Fu, P. Hu, L. Zhao, H. Zhang, X. Tang, and et al. The diagnostic value of monoclonal gastric cancer 7 antigen: a systematic review with meta-analysis Clin Exp Med 14 2014 337 343
56. H. Umemura, A. Togawa, K. Sogawa, K. Satoh, K. Mogushi, M. Nishimura, and et al. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis J Gastroenterol 46 2011 577 585
57. X. Zhou, W. Zhu, H. Li, W. Wen, W. Cheng, F. Wang, and et al. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis Sci Rep 5 2015 Jun 10 11251 10.1038/srep11251
58. H. Amal, M. Leha, K. Funka, R. Skapars, A. Sivins, G. Ancans, and et al. Detection of precancerous gastric lesions and gastric cancer through exhaled breath Gut 2015 April 13 10.1136/gutjnl-2014-308536 gutjnl-2014-308536
59. K. Sugano, J. Tack, E.J. Kuipers, D.Y. Graham, E.M. El-Omar, S. Miura, and et al. Kyoto global consensus report on Helicobacter pylori gastritis Gut 64 2015 1353 1367
60. J. Ueda, M. Gosho, Y. Inui, T. Matsuda, M. Sakakibara, K. Mabe, and et al. Prevalence of Helicobacter pylori infection with healthy subjects in Japan Helicobacter 19 2014 105 110
61. S. Kato, N. Matsukura, K. Tsukada, N. Matsuda, T. Mizoshita, T. Tsukamoto, and et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics Cancer Sci 98 2007 790 794
62. K. Sugano, H. Osawa, and K. Satoh Clinical management of H. pylori-the Japanese perspective Dig Dis 32 2014 281 289
63. K. Murakami, Y. Sakurai, M. Shiino, N. Funao, A. Nishimura, and M. Asaka A phase 3, randomized, double-blind study of a triple therapy with TAK-438, amoxicillin and clarithromycin as first line eradication of H. pylori and a triple therapy with TAK-438, amoxicillin and metronidazole as second line eradication of H. pylori Gastroenterology 146 Suppl. 1 2014 S-74 [abstract]